Mid and South Essex NHS Trust

Yazan Masannat is a Consultant Oncoplastic Breast Surgeon based at Broomfield Hospital in Essex. He has many areas of specialist interest in Breast Cancer Surgery including Oncoplastic Breast Surgery, Breast Reconstruction, and Revision Surgery after breast cancer treatment.

Yazan has more than 80 peer reviewed publications and has been awarded numerous research grants. He is the Simulation Lead at Broomfield Hospital and a visiting Associate Professor at Anglia Ruskin University, Cambridge. He is also an Honorary Senior Clinical Lecturer at Queen Mary’s University of London, the University of Aberdeen/Scotland and an E-Tutor with the University of East Anglia/England.  

He is the Meetings Secretary and an elected member of the Board of Trustees of the Association of Breast Surgery, in addition to being an examiner at the European Board of Surgical Oncology and the European Board of Breast Surgery exams (UEMS). 

Yazan is the creator of www.iBreastBook.com which is a free online resource with contributions from many of the leading Breast and Plastic surgeons across the world. The iBreastBook Webinar series, which started during the covid pandemic has been a huge international success. As a result, Yazan is regularly invited worldwide to lecture and teach on the different Oncoplastic Breast Surgical Techniques. 

Uppsala University Hospital, Sweden

The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research

Dr Anna Kirby is a Consultant Clinical Oncologist in the UK specialising in the treatment of patients with breast cancer. She leads research into novel breast radiotherapy techniques at The Royal Marsden and Institute of Cancer Research (ICR), London. She was appointed as a Reader at the ICR in 2022. She is Technical Radiotherapy Lead for the UK Breast Proton Trial (PARABLE), Chief Investigator of the UK HeartSpare studies, Chief Clinical Co-ordinator of the IMPORT breast radiotherapy trials, and Breast Lead Investigator on the CORE trial evaluating the role of stereotactic radiotherapy in treating oligometastatic disease. 

Dr Kirby is current President of the European Society for Radiotherapy and Oncology (ESTRO) which facilitates radiation oncology research dissemination, education, training, interdisciplinary collaboration, professional support and advocacy across Europe and beyond.

The Royal Derby Hospital

Amit Goyal is a Consultant Oncoplastic Breast Surgeon & Associate Professor at the Royal Derby Hospital, UK. His research is focused on axillary management in breast cancer. He is the Chief Investigator of the largest breast cancer surgical trials addressing the role of axillary treatment in the UK – POSNOC and ATNEC.

Nightingale Breast Cancer Centre, Manchester, UK

Cliona is an Oncoplastic Breast Surgeon at the Nightingale Breast Cancer Centre in Manchester, UK. She studied medicine, including a BSc in the History of Medicine, at Charing Cross and Westminster Medical School, London and University College London. Her surgical training was in London, Bristol, Bournemouth, South Africa and Greater Manchester. She completed a PhD entitled ‘The Role of Procoagulants in Cancer and Chemotherapy Induced Venous Thromboembolism’ at the University of Manchester in 2006.

She delivers and teaches in all forms of oncoplastic breast surgery including reconstruction. At the University of Manchester, she leads the Cancer and Thrombosis Research Group, performing basic, translational and clinical research, investigating the symbiotic relationship between cancer and thrombosis. She also supervises MRes, MD and PhD students.

She is Chief Investigator on the TIP Trial and CHAMPion Study and surgical lead for LORIS, PRIMETIME, POETIC-A and FAST-Forward Boost and is on the Sloane Committee. Cliona leads the Association of Breast Surgery guideline development group for Idiopathic Granulomatous Mastitis and is a key member of the International Society of Haemostasis and Thrombosis guideline development group for VTE in breast cancer. She is Director of the North West Surgical Trials Centre, and mentors the North West Research Collaborative and North West Breast Research Collaborative. She also chairs the ABS Academic and Research Committee and the Scientific Committee for the Prevent Breast Cancer charity.

In her personal life, she enjoys dressmaking, knitting and endurance sports, having previously completed two Ironmans and the Everest Marathon.

Research interests include prediction of local treatment side-effects (toxicity) in the breast using clinical and molecular markers, population-based studies of breast surgery and reconstruction outcomes, and qualitative exploration of patients’ views of breast cancer treatments and clinical decision-making.  As academic surgical trainee, other leadership roles include Member of the international Radiogenomics Consortium, Member of the Mammary Fold Academic & Research Committee, and co-PI on two national trainee collaborative studies.

University of Oxford

David Dodwell is a senior clinical oncologist working in Oxford Population Health in The University of Oxford and Oxford University Hospitals NHS Trust. He has a 20+-year special interest in the management of breast cancer. He is co-oncology lead for the new national breast cancer audits, is involved in many epidemiological studies in breast cancer and works within The Early Breast Cancer Trialists’ Collaborative Group (EBCTCG).

University of Florence

Associate Professor at the Department of Clinical and Experimental Biomedical Sciences “M. Serio” of the University of Florence (Florence, Italy), Icro Meattini works as Clinical Oncologist since 2011 at the Radiation Oncology Unit of the Oncology Department at the Florence University Hospital, where is responsible for the Outpatient Clinics Unit, Clinical Trials Unit, and leader of the Clinical Oncology Group of the Breast Cancer Multidisciplinary Team (MDT).

University of Antwerp

Newcastle Upon Tyne Hospitals NHS Trust

Henry Cain qualified in 2001 from Leicester Medical School. Following the award of MD in breast cancer signalling pathways and higher surgical training in Newcastle upon Tyne he spent a year as the Oncoplastic Fellow at the Canniesburn Unit in Glasgow. He was appointed a Consultant Oncoplastic Surgeon at the Royal Victoria Infirmary Newcastle upon Tyne in 2013.  Driving improvements in surgical care he has led the introduction of Radioactive Seed Localisation of impalpable breast cancer and post neo-adjuvant chemotherapy I125 seed Targeted Axillary Dissection to the UK.  With a significant recruitment into national trials he is the surgical lead Co-Investigator for the NOSTRA trial and the Chief Investigator for the PRE-DX national RCT. In 2025 He was appointed to the ABS executive (Honorary Treasurer) and the Breast Surgical Specialties lead for research at the Royal College of Surgeons. 

North Bristol NHS Trust and Bristol Medical School

Shelley Potter is Professor of Surgical Oncology at Bristol Medical School and Consultant Oncoplastic Breast Surgeon at North Bristol NHS Trust. Her research interests focus on improving outcomes for women undergoing breast surgery by generating high quality evidence to support clinical practice and decision-making. She is currently Chief Investigator of the PreBRA, ANTHEM and Brighter studies, Shelley is also Royal College of Surgeons of England Surgical Specialty Lead for Breast Surgery, Chair of the iBRA-NET group and Secretary to the ABS Academic and Research Committee and the British Breast Group.

Liverpool University Hospitals

Imperial College Healthcare NHS Trust

Daniel is a Professor in Breast Surgery working in the Departments of BioSurgery and Surgical Technology, the Hamlyn Centre for Robotic Surgery and the Cancer Research UK Centre at Imperial College London. Daniel is Co-PI on the CRUK funded “REI-EXCISE” trial which seeks to validate a mass-spectrometry based intelligent knife or “iKnife” as an immediate margin detection system to improve the precision of breast conserving surgery, reduce re-operative intervention, and enhance
quality of life. He leads a UK wide team working on a CRUK-EPSRC funded project “MAMMOBOT” to design a flexible growing ductoscopic robot for early breast cancer detection.

Daniel Co-Chairs the “Precision Therapy” theme of Imperial’s CRUK Centre and represents cancer surgery for the Imperial ECMC. He has published over 150 scientific papers in peer-reviewed journals on subjects relating to the application of surgical technologies, sensing and robotics to improve cancer surgery. His teams research has won national and international recognition, including the Hounsfield Prize, British Journal of Surgery Prize (ABS), Patey Prize (SARS), Sir Pat Forrest Award (BBG), Parasuraman Award, Athanasiou Medal (ABME), and the young scientist award nomination at MICCAI. He has attracted funding from Industry (Waters Corp, Hitachi Medical Corp), the Academy of Medical Sciences and Wellcome Trust, Engineering and Physical Sciences Research Council, Association of Breast Surgery, Cancer Research UK, and the National Institute for Health and Care Research.

Daniel won the Ronald Raven Prize Travelling Fellowship to learn from experts in Breast Cancer and Reconstructive Surgery at the MD Anderson Cancer Center, the forefront Cancer Center in USA, and more recently the Price Thomas Fellowship of the Travelling Surgeons of Great Britain and Ireland. More recently he won the highly prestigious James IV Travelling Association of Surgeons. He has delivered a number of key-note lectures including “McGuire Lecture in Surgical Oncology”(Queens University, Kingston, Canada).

Imperial Healthcare NHS Trust

Susan Cleator is a Clinical oncologist based at Charing Cross, Imperial, London. She overseas a radiation and also early and late systemic treatment practice. Her training incorporated a PhD investigating the value of expression profiling in predicting response of breast cancers to neoadjuvant chemotherapy at the ICR/ RMH and she has retained an interest in genomic profiling and neoadjuvant therapy for breast cancers. She is a local PI on a range of breast studies, sits on the TMG and IDMC of a number of breast radiation and systemic treatment studies and is Radiotherapy Lead for the soon to open PRADA 2 radiation study. She is a member of the UKBCS committee. She contributes to national meetings by lecturing and participating in expert panels.

University of Oxford

Mr Gurdeep S. Mannu is a Cancer Research UK Clinician Scientist at the University of Oxford. His research focuses on the epidemiology of breast cancer.

Manchester University NHS Foundation Trust

Oncoplastic breast surgeon with research interests in commercial device studies.

University College London

Dr. Tom Richards is a Consultant Clinical Oncologist at University College London Hospitals NHS Foundation Trust (UCLH) and an honorary consultant at The Whittington

James Paget Healthcare NHS Trust

Ms Downey qualified from Nottingham University in the last century and she undertook SHO training in Bristol, Research in Breast Cancer Oncology in Manchester and Registrar training in Yorkshire. Her first consultant post in Bradford for 4 years and moved to East Anglia in 2005. Sarah's first involvement in RCS was examiner for MRCS at time OSCE introduced. Acted on committee and then Chair of Court of Examiners for RCS England. Part of training committee since came to East Anglia in 2005. Undertook Divisional Director role in own hospital for 5 years – opened new daycase unit. Acted as regional Breast Screening QA Surgeon for 6 years. Joined SAC in 2015 and became regional TPD in 2018. Currently Chair of General Surgery SAC.  Undergraduate PBL tutor and online tutor for oncoplastic MS. Director of Screening for own Trust and also Clinical Appraisal Lead. Former TIG Chair and faculty on Advanced Breast Cancer Course. Currently President of ABS.